Published in Clin Infect Dis on August 16, 2002
Community-associated methicillin-resistant Staphylococcus aureus: epidemiology and clinical consequences of an emerging epidemic. Clin Microbiol Rev (2010) 9.82
Community-acquired Methicillin-resistant Staphylococcus aureus: Epidemiology and Potential Virulence Factors. Curr Infect Dis Rep (2003) 0.96
Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur J Clin Microbiol Infect Dis (2003) 0.96
Prevalence of USA300 colonization or infection and associated variables during an outbreak of community-associated methicillin-resistant Staphylococcus aureus in a marginalized urban population. Can J Infect Dis Med Microbiol (2007) 0.89
Staphylococcus aureus colonization and infection among drug users: identification of hidden networks. Am J Public Health (2011) 0.87
Expansion of Microbial Forensics. J Clin Microbiol (2016) 0.84
Persistence of a methicillin-resistant Staphylococcus aureus clone in a drug-use network. Clin Infect Dis (2003) 0.82
Low mortality but increasing incidence of Staphylococcus aureus endocarditis in people who inject drugs: Experience from a Swedish referral hospital. Medicine (Baltimore) (2016) 0.75
High rates of abscesses and chronic wounds in community-recruited injection drug users and associated risk factors. J Addict Med (2015) 0.75
Increasing the reach of forensic genetics with massively parallel sequencing. Forensic Sci Med Pathol (2017) 0.75
Pathogenesis of methicillin-resistant Staphylococcus aureus infection. Clin Infect Dis (2008) 3.88
Human papillomavirus type 16 and immune status in human immunodeficiency virus-seropositive women. J Natl Cancer Inst (2003) 2.81
The clonality of Staphylococcus aureus nasal carriage. J Infect Dis (2005) 2.39
Antimicrobial-resistant bacteria in the community setting. Nat Rev Microbiol (2006) 2.18
Mortality in an urban cohort of HIV-infected and at-risk drug users in the era of highly active antiretroviral therapy. Clin Infect Dis (2005) 2.15
Heterosexual transmission of community-associated methicillin-resistant Staphylococcus aureus. Clin Infect Dis (2007) 2.13
Development of proteinuria or elevated serum creatinine and mortality in HIV-infected women. J Acquir Immune Defic Syndr (2003) 2.11
A postinfluenza model of Staphylococcus aureus pneumonia. J Infect Dis (2010) 2.09
Identification of a highly transmissible animal-independent Staphylococcus aureus ST398 clone with distinct genomic and cell adhesion properties. MBio (2012) 2.00
Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection. AIDS (2007) 1.95
Transitions to injecting drug use among noninjecting heroin users: social network influence and individual susceptibility. J Acquir Immune Defic Syndr (2006) 1.88
Staphylococcus aureus ST398, New York City and Dominican Republic. Emerg Infect Dis (2009) 1.83
Prevalence and cumulative incidence of and risk factors for anemia in a multicenter cohort study of human immunodeficiency virus-infected and -uninfected women. Clin Infect Dis (2001) 1.79
Bacterial infections in drug users. N Engl J Med (2005) 1.78
Emergence of sequence type 398 as a community- and healthcare-associated methicillin-susceptible staphylococcus aureus in northern Manhattan. Clin Infect Dis (2013) 1.75
Comorbid conditions, treatment, and health maintenance in older persons with human immunodeficiency virus infection in New York City. Clin Infect Dis (2002) 1.73
Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.71
Overweight and human immunodeficiency virus (HIV) progression in women: associations HIV disease progression and changes in body mass index in women in the HIV epidemiology research study cohort. Clin Infect Dis (2003) 1.70
Risk correlates of prevalent HIV, hepatitis B virus, and hepatitis C virus infections among noninjecting heroin users. J Acquir Immune Defic Syndr (2002) 1.68
Meticillin-resistant Staphylococcus aureus among US prisoners and military personnel: review and recommendations for future studies. Lancet Infect Dis (2006) 1.60
The environment as an unrecognized reservoir for community-associated methicillin resistant Staphylococcus aureus USA300: a case-control study. PLoS One (2011) 1.57
Serum immunoglobulin G response to human papillomavirus type 16 virus-like particles in human immunodeficiency virus (HIV)-positive and risk-matched HIV-negative women. J Infect Dis (2003) 1.57
The effect of highly active antiretroviral therapy on human papillomavirus clearance and cervical cytology. Obstet Gynecol (2009) 1.56
Molecular tracing of the emergence, diversification, and transmission of S. aureus sequence type 8 in a New York community. Proc Natl Acad Sci U S A (2014) 1.49
Gender differences in injection risk behaviors at the first injection episode. Drug Alcohol Depend (2007) 1.47
The use of a critical care consult team to identify risk for methicillin-resistant Staphylococcus aureus infection and the potential for early intervention: a pilot study. Crit Care Med (2010) 1.47
Interpreting the association between HIV and bone mineral density. AIDS (2007) 1.43
HIV mono-infection is associated with FIB-4 - A noninvasive index of liver fibrosis - in women. Clin Infect Dis (2011) 1.37
Outcomes after treatment of cervical intraepithelial neoplasia among women with HIV. J Low Genit Tract Dis (2007) 1.37
Ventricular assist device-related infections. Lancet Infect Dis (2006) 1.37
Prevalence, incidence, and persistence or recurrence of trichomoniasis among human immunodeficiency virus (HIV)-positive women and among HIV-negative women at high risk for HIV infection. Clin Infect Dis (2002) 1.35
Current sexual activity and risky sexual behavior in older men with or at risk for HIV infection. AIDS Educ Prev (2007) 1.33
Staphylococcus aureus colonization and the risk of infection in critically ill patients. Infect Control Hosp Epidemiol (2005) 1.32
High-risk human papillomavirus reactivation in human immunodeficiency virus-infected women: risk factors for cervical viral shedding. Obstet Gynecol (2010) 1.31
Time to clearance of human papillomavirus infection by type and human immunodeficiency virus serostatus. Int J Cancer (2006) 1.28
Staphylococcus aureus oropharyngeal carriage in a prison population. Clin Infect Dis (2011) 1.28
Longitudinal study of mucosal Candida species colonization and candidiasis among human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women. J Infect Dis (2003) 1.28
Prevalence of and risk factors for viral infections among human immunodeficiency virus (HIV)-infected and high-risk HIV-uninfected women. J Infect Dis (2003) 1.27
Contribution of selected gene mutations to resistance in clinical isolates of vancomycin-intermediate Staphylococcus aureus. Antimicrob Agents Chemother (2012) 1.27
Injecting and sexual risk correlates of HBV and HCV seroprevalence among new drug injectors. Drug Alcohol Depend (2007) 1.26
Gender and hospitalization patterns among HIV-infected drug users before and after the availability of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 1.24
Methicillin-susceptible Staphylococcus aureus ST398, New York and New Jersey, USA. Emerg Infect Dis (2012) 1.23
Hepatitis C infection is associated with lower lipids and high-sensitivity C-reactive protein in HIV-infected men. AIDS Patient Care STDS (2007) 1.22
Factors associated with successful referral for clinical care of drug users with chronic hepatitis C who have or are at risk for HIV infection. J Acquir Immune Defic Syndr (2004) 1.21
Rates and risk factors for condition-specific hospitalizations in HIV-infected and uninfected women. J Acquir Immune Defic Syndr (2003) 1.20
Smoking and time to clearance of human papillomavirus infection in HIV-seropositive and HIV-seronegative women. Am J Epidemiol (2006) 1.20
The association of hepatitis C prevalence, activity, and genotype with HIV infection in a cohort of New York City drug users. J Acquir Immune Defic Syndr (2003) 1.19
Human papillomavirus capsid antibody response to natural infection and risk of subsequent HPV infection in HIV-positive and HIV-negative women. Cancer Epidemiol Biomarkers Prev (2005) 1.17
Staphylococcus aureus in the community: colonization versus infection. PLoS One (2009) 1.16
Sexual and other noninjection risks for HBV and HCV seroconversions among noninjecting heroin users. J Infect Dis (2007) 1.14
Crack cocaine use and other risk factors for tuberculin positivity in drug users. Clin Infect Dis (2002) 1.14
Effectiveness of barrier precautions and surveillance cultures to control transmission of multidrug-resistant organisms: a systematic review of the literature. Am J Infect Control (2006) 1.13
Association of hepatitis C infection and antiretroviral use with diabetes mellitus in drug users. Clin Infect Dis (2003) 1.12
Characterization of genital human papillomavirus infection in women who have or who are at risk of having HIV infection. Am J Obstet Gynecol (2002) 1.12
Challenges and strategies for research in prisons. Public Health Nurs (2012) 1.12
Staphylococcus aureus CC398 clade associated with human-to-human transmission. Appl Environ Microbiol (2012) 1.10
Secrets of a superbug. Nat Med (2007) 1.07
A national survey of alcohol screening and referral in college health centers. J Am Coll Health (2004) 1.07
Prospective study of bone mineral density changes in aging men with or at risk for HIV infection. AIDS (2010) 1.06
Update on the prevention and control of community-acquired meticillin-resistant Staphylococcus aureus (CA-MRSA). Int J Antimicrob Agents (2012) 1.05
Effect of left ventricular assist device infection on post-transplant outcomes. J Heart Lung Transplant (2009) 1.05
Influence of sex hormones, HIV status, and concomitant sexually transmitted infection on cervicovaginal inflammation. J Infect Dis (2004) 1.04
Prospective, multicenter study of ventricular assist device infections. Circulation (2013) 1.03
Vaccination with clumping factor A and fibronectin binding protein A to prevent Staphylococcus aureus infection of an aortic patch in mice. J Infect Dis (2008) 1.03
Gender differences in illicit substance use among middle-aged drug users with or at risk for HIV infection. Clin Infect Dis (2006) 1.02
Pediatric reference ranges for zinc protoporphyrin. Clin Biochem (2003) 1.01
The role of Staphylococcus aureus adhesins in the pathogenesis of ventricular assist device-related infections. J Infect Dis (2006) 1.01
Molecular characterization of methicillin-susceptible Staphylococcus aureus clinical isolates in the United States, 2004 to 2010. J Clin Microbiol (2013) 1.01
SdrF, a Staphylococcus epidermidis surface protein, contributes to the initiation of ventricular assist device driveline-related infections. PLoS Pathog (2009) 1.00
Association of HIV viral load with monocyte chemoattractant protein-1 and atherosclerosis burden measured by magnetic resonance imaging. AIDS (2009) 0.99
Mortality rates and causes of death in a cohort of HIV-infected and uninfected women, 1993-1999. J Urban Health (2003) 0.99
Cardiovascular implications of HIV-induced dyslipidemia. Atherosclerosis (2011) 0.98
Differences between Staphylococcus aureus isolates from medical and nonmedical hospital personnel. J Clin Microbiol (2002) 0.98
Antimicrobial strategies for the prevention and treatment of cardiovascular infections. Curr Opin Pharmacol (2003) 0.97
SdrF, a Staphylococcus epidermidis surface protein, binds type I collagen. J Biol Chem (2007) 0.96
High prevalence of colonization with Staphylococcus aureus clone USA300 at multiple body sites among sexually transmitted disease clinic patients: an unrecognized reservoir. Microbes Infect (2012) 0.95
Use of complementary and alternative medicine in inner-city persons with or at risk for HIV infection. AIDS Patient Care STDS (2008) 0.95
Clinical and immunologic progression in HIV-infected US women before and after the introduction of highly active antiretroviral therapy. J Acquir Immune Defic Syndr (2003) 0.94
The impact of HIV infection and immunodeficiency on human papillomavirus type 6 or 11 infection and on genital warts. Sex Transm Dis (2002) 0.93
Mechanisms by which tumor cells and monocytes expressing the angiogenic factor thymidine phosphorylase mediate human endothelial cell migration. Cancer Res (2003) 0.93
The influence of human leukocyte antigen class I alleles and their population frequencies on human immunodeficiency virus type 1 control among African Americans. Hum Immunol (2011) 0.93
Bacterial vaginosis and the natural history of human papillomavirus. Infect Dis Obstet Gynecol (2011) 0.93
Toward an understanding of the evolution of Staphylococcus aureus strain USA300 during colonization in community households. Genome Biol Evol (2012) 0.93
Effect of HIV infection on atypical squamous cells of undetermined significance. Clin Infect Dis (2006) 0.92
Vaginal flora morphotypic profiles and assessment of bacterial vaginosis in women at risk for HIV infection. Infect Dis Obstet Gynecol (2005) 0.92
Incidence and persistence of Staphylococcus aureus nasal colonization in a community sample of HIV-infected and -uninfected drug users. Clin Infect Dis (2007) 0.92